1-3 of 3
Steve Burt, NP
Close
Sort by
Journal Articles

Combination of Bendamustine, Lenalidomide, and Dexamethasone (BLD) in Patients with Refractory or Relapsed Multiple Myeloma Is Safe and Highly Effective: Results of Phase I/II Open-Label, Dose Escalation Study

Suzanne Lentzsch, MD, PhD, Amy O'Sullivan, RN, BSN, Ryan Kennedy, BS, Mohammad Abbas, MD, Navkiranjit Gill, DO, Lijun Dai, MD, PhD, Carrie Andreas, PA-C, Diane Gardner, MSN, CRNP, BC, Silvana Lalo Pregja, MBA, Steve Burt, NP, Robert L. Redner, MD, Robert Volkin, MD, G. David Roodman, MD, PhD, Markus Y. Mapara, MD, PhD, J. Franklin Viverette, MD, Mounzer Agha, MD, John K. Waas, DO, Yongli Shuai, MS, Daniel Normolle, PhD, Jeffrey A. Zonder, MD
Journal: Blood
Blood (2011) 118 (21): 304.
https://doi.org/10.1182/blood.V118.21.304.304
Published: 2011
Journal Articles

Combination of Bendamustine, Lenalidomide, and Dexamethasone In Patients with Refractory or Relapsed Multiple Myeloma Is Safe and Highly Effective: Results of a Phase I Clinical Trial

Suzanne Lentzsch, MD, PhD, Amy O'Sullivan, RN, BSN, Ryan Kennedy, BS, Navkiranjit Gill, DO, Carrie Andreas, PA-C, Diane Gardner, MSN, CRNP, BC, Silvana Lalo, MBA, Steve Burt, NP, Robert L. Redner, MD, Robert Volkin, MD, David Roodman, MD, PhD, Markus Y Mapara, MD, PhD, Frank Viverette, MD, Mounzer Agha, MD, Jeffrey A. Zonder, MD
Journal: Blood
Blood (2010) 116 (21): 989.
https://doi.org/10.1182/blood.V116.21.989.989
Published: 2010
Journal Articles

A Phase I Study of Bendamustine Combined with Lenalidomide and Dexamethasone in Patients with Refractory or Relapsed Multiple Myeloma.

Suzanne Lentzsch, MD, PhD, Amy O’Sullivan, RN, BSN, Silvana Lalo, MBA, Carrie Kruppa, MPAS, PA-C, Diane Gardner, RN, CRNP, Ryan C Kennedy, BS, Steve Burt, NP, Markus Y Mapara, MD, PhD, Robert Redner, MD, David Roodman, MD, PhD, Robert L Volkin, MD, Jeffrey Zonder, MD
Journal: Blood
Blood (2009) 114 (22): 1856.
https://doi.org/10.1182/blood.V114.22.1856.1856
Published: 2009